Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Supernus Pharmaceuticals, Inc. company logo
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN)

Profile

Company profile for Supernus Pharmaceuticals, Inc. (SUPN)
MetricValue
Full NameSupernus Pharmaceuticals, Inc.
TickerNASDAQ: SUPN
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websitesupernus.com
Employees674

Key Metrics

Supernus Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$49.47
Price, 1D Change-0.46%
Market Cap$3B
-
PE Ratio-
Beta0.43
Revenue$662M
Revenue, 1Y Change+8.94%
EPS$1.32
EPS, 1Y Change+5,469.62%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Supernus Pharmaceuticals, Inc. chart

Events

Supernus Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

SUPN Estimates
MetricDateValue
EPS$1.32
EPS Estimate$3.81
EPS Est. Change+188.89%
Revenue$661.82M
Revenue Estimate$703.00M
Revenue Est. Change+6.22%
Current Price$49.47
Price Target-$61.50
Price Tgt. Change-+24.32%

🔒 Log In To Unlock Full Data

EPS

SUPN EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$1.98$0.02-98.80%
$2.87$1.32-54.06%
$3.81N/A+188.89%
$4.25N/A+221.72%
SUPN EPS reported versus estimate values chart

Revenue

SUPN revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$598.26M$607.52M+1.55%
$642.90M$661.82M+2.94%
$703.00MN/A+6.22%
$867.27MN/A+31.04%
SUPN revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

SUPN Performance
MetricDateValue
Price, 1Y+35.79%
Price, 3Y+38.69%
Market Cap, 1Y+39.68%
Market Cap, 3Y+46.58%
Revenue, 1Y+8.94%
Revenue, 3Y+14.15%
EPS, 1Y+5,469.62%
EPS, 3Y+34.31%

🔒 Log In To Unlock Full Data

Technical Indicators

SUPN Technical Indicators
MetricDateValue
Current Price$49.47
SMA 200$40.09
SMA 200 vs Price-18.96%
SMA 50$48.50
SMA 50 vs Price-1.96%
Beta0.43
ATR$1.44
14-Day RSI53.87
10-Day Volatility28.45%
1-Year Volatility38.55%

Dividends

SUPN Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

SUPN Income & Profitability
MetricDateValue
Revenue$661.82M
EPS$1.32
Gross Profit$503.50M
Gross Margin76.08%
Operating Profit$75.56M
Operating Margin11.42%
Net Income$73.87M
Net Margin11.16%
EBITDA$178.28M

🔒 Log In To Unlock Full Data

Financial Health

SUPN Financial Health
MetricDateValue
Debt To Equity0.03
Current Ratio2.35
Quick Ratio2.16
Interest Coverage-
F-Score2
Altman Z-Score5.15

Valuations

SUPN Valuations
MetricDateValue
PE Ratio-
PS Ratio4.16
PB Ratio2.70
EV/EBITDA49.53
Enterprise ValueN/A-

Balance Sheet

SUPN Balance Sheet
MetricDateValue
Book Value$1.04B
Cash & Equivalents$453.61M
Total Assets$1.50B
Current Assets$686.07M
Total Liabilities$465.07M
Current Liabilities$292.40M
Total Debt$34.27M
Short Term Debt$6.89M
Accounts Payable$4.59M

Expenses

SUPN Expenses
MetricDateValue
Total Expenses$586.26M
Operating Expenses$508.36M
Cost Of Goods Sold$158.32M
SG&A$321.58M
D&A$80.41M
Interest Expense$0.00
Income Tax$24.01M

Cash Flow

SUPN Cash Flow
MetricDateValue
CFO$171.95M
CFI-$189.87M
CFF$12.19M
Capex$725.00K
Free Cash Flow$171.23M

Recent analyst updates

SUPN Recent analyst updates
MetricDateValue
Stifel→
B of A Securities
TD Cowen→
Piper Sandler→
Cantor Fitzgerald→
Piper Sandler→
Cantor Fitzgerald→
Cantor Fitzgerald→
Cantor Fitzgerald→
Piper Sandler→

Analyst sentiment

Sentiment over the past month
SUPN analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
SUPN institutional ownership distribution chart

Screeners with SUPN

Data Sources & References

  1. SUPN Official Website www.supernus.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1356576/000135657625000071/0001356576-25-000071-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1356576/000135657625000017/0001356576-25-000017-index.htm
  4. SUPN Profile on Yahoo Finance finance.yahoo.com/quote/SUPN
  5. SUPN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/supn

FAQ

  • What is the ticker symbol for Supernus Pharmaceuticals, Inc.?

    The ticker symbol for Supernus Pharmaceuticals, Inc. is NASDAQ:SUPN

  • Does Supernus Pharmaceuticals, Inc. pay dividends?

    No, Supernus Pharmaceuticals, Inc. does not pay dividends

  • What sector is Supernus Pharmaceuticals, Inc. in?

    Supernus Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Supernus Pharmaceuticals, Inc. in?

    Supernus Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is Supernus Pharmaceuticals, Inc. based in?

    Supernus Pharmaceuticals, Inc. is headquartered in United States

  • When did Supernus Pharmaceuticals, Inc. go public?

    Supernus Pharmaceuticals, Inc. initial public offering (IPO) was on May 1, 2012

  • Is Supernus Pharmaceuticals, Inc. in the S&P 500?

    No, Supernus Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Supernus Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Supernus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Supernus Pharmaceuticals, Inc. in the Dow Jones?

    No, Supernus Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Supernus Pharmaceuticals, Inc. last earnings report?

    Supernus Pharmaceuticals, Inc.'s most recent earnings report was on November 4, 2025

  • When does Supernus Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Supernus Pharmaceuticals, Inc. is February 24, 2026